Target intelligence / Profile preview

Bifidobacterium longum alpha-xyloside-binding protein (BlAXBP)

Target
BlAXBP
Molecular classification
Solute-binding protein, ABC transporter component, Carbohydrate-binding protein
01

Overview

Bifidobacterium longum alpha-xyloside-binding protein (BlAXBP) is a specialized solute-binding protein found in the human gut commensal bacterium Bifidobacterium longum. It plays a critical role in the transport and metabolism of xyloglucan-derived oligosaccharides, specifically recognizing and binding alpha-xylosides with high affinity to facilitate their entry into the cell via an ABC transporter system (Ejby et al., 2013, J. Biol. Chem.). This protein is essential for the bacterium's ability to utilize complex plant-derived dietary fibers, which provides a competitive advantage in the gut environment. While not a traditional human therapeutic target, BlAXBP is of significant interest in microbiome research and the development of prebiotics, as it defines the niche specificity of beneficial gut microbes. Understanding its structural basis for ligand recognition helps in designing dietary interventions to promote gut health and manage metabolic or inflammatory diseases associated with microbiome dysbiosis.

Other names
Alpha-xyloside-binding proteinBLLONG_0549Solute-binding protein BlAXBP
02

Mechanism of action

Not applicable as this is not a human therapeutic target; it functions as a substrate-binding protein for ABC transporters in gut bacteria.

03

Biological functions

Carbohydrate transportXyloglucan metabolismPrebiotic utilizationLigand binding
04

Disease associations

Gut microbiome dysbiosis
05

Safety considerations

Targeting bacterial proteins may disrupt commensal gut flora

Beyond the preview

Go deeper on Bifidobacterium longum alpha-xyloside-binding protein (BlAXBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bifidobacterium longum alpha-xyloside-binding protein (BlAXBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call